 | • レポートコード：MRC2-11QY11184 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は脳腫瘍治療薬のグローバル市場について調査・分析したレポートです。種類別（手術、放射線療法、標的療法、化学療法、免疫療法）市場規模、用途別（病院、腫瘍治療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別脳腫瘍治療薬の競争状況、市場シェア ・世界の脳腫瘍治療薬市場：種類別市場規模 2015年-2020年（手術、放射線療法、標的療法、化学療法、免疫療法） ・世界の脳腫瘍治療薬市場：種類別市場規模予測 2021年-2026年（手術、放射線療法、標的療法、化学療法、免疫療法） ・世界の脳腫瘍治療薬市場：用途別市場規模 2015年-2020年（病院、腫瘍治療センター、その他） ・世界の脳腫瘍治療薬市場：用途別市場規模予測 2021年-2026年（病院、腫瘍治療センター、その他） ・北米の脳腫瘍治療薬市場分析：米国、カナダ ・ヨーロッパの脳腫瘍治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの脳腫瘍治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の脳腫瘍治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの脳腫瘍治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Novartis、Roche、Merck、AstraZeneca、GE Healthcare、Hitachi Medical、Philips Healthcare、Novocure、DelMar Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A brain tumor occurs when abnormal cells form within the brain.
North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics market owing to factors, such as increasing accessibility to healthcare facilities in the region, and increasing geriatric population.
Market Analysis and Insights: Global Brain Tumor Therapeutics Market
The global Brain Tumor Therapeutics market size is projected to reach US$ 1146.8 million by 2026, from US$ 1030.4 million in 2020, at a CAGR of 10.4%% during 2021-2026.
Global Brain Tumor Therapeutics Scope and Market Size
Brain Tumor Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Brain Tumor Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Novartis
Roche
Merck
AstraZeneca
GE Healthcare
Hitachi Medical
Philips Healthcare
Novocure
DelMar Pharmaceuticals
Market segment by Type, the product can be split into
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Immunotherapy
Market segment by Application, split into
Hospitals
Oncology Treatment Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Brain Tumor Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Brain Tumor Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Radiation Therapy
1.4.4 Targeted Therapy
1.4.5 Chemotherapy
1.4.6 Immunotherapy
1.5 Market by Application
1.5.1 Global Brain Tumor Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Oncology Treatment Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Brain Tumor Therapeutics Market Perspective (2015-2026)
2.2 Global Brain Tumor Therapeutics Growth Trends by Regions
2.2.1 Brain Tumor Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Brain Tumor Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Brain Tumor Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Brain Tumor Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Brain Tumor Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Brain Tumor Therapeutics Players by Market Size
3.1.1 Global Top Brain Tumor Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Brain Tumor Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Brain Tumor Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Brain Tumor Therapeutics Market Concentration Ratio
3.2.1 Global Brain Tumor Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Brain Tumor Therapeutics Revenue in 2019
3.3 Brain Tumor Therapeutics Key Players Head office and Area Served
3.4 Key Players Brain Tumor Therapeutics Product Solution and Service
3.5 Date of Enter into Brain Tumor Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Brain Tumor Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Brain Tumor Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Brain Tumor Therapeutics Market Size by Application (2015-2020)
5.2 Global Brain Tumor Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Brain Tumor Therapeutics Market Size (2015-2020)
6.2 Brain Tumor Therapeutics Key Players in North America (2019-2020)
6.3 North America Brain Tumor Therapeutics Market Size by Type (2015-2020)
6.4 North America Brain Tumor Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Brain Tumor Therapeutics Market Size (2015-2020)
7.2 Brain Tumor Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Brain Tumor Therapeutics Market Size by Type (2015-2020)
7.4 Europe Brain Tumor Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Brain Tumor Therapeutics Market Size (2015-2020)
8.2 Brain Tumor Therapeutics Key Players in China (2019-2020)
8.3 China Brain Tumor Therapeutics Market Size by Type (2015-2020)
8.4 China Brain Tumor Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Brain Tumor Therapeutics Market Size (2015-2020)
9.2 Brain Tumor Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Brain Tumor Therapeutics Market Size by Type (2015-2020)
9.4 Japan Brain Tumor Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Brain Tumor Therapeutics Market Size (2015-2020)
10.2 Brain Tumor Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Brain Tumor Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Brain Tumor Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Brain Tumor Therapeutics Market Size (2015-2020)
11.2 Brain Tumor Therapeutics Key Players in India (2019-2020)
11.3 India Brain Tumor Therapeutics Market Size by Type (2015-2020)
11.4 India Brain Tumor Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Brain Tumor Therapeutics Market Size (2015-2020)
12.2 Brain Tumor Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Brain Tumor Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Brain Tumor Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Brain Tumor Therapeutics Introduction
13.1.4 Pfizer Revenue in Brain Tumor Therapeutics Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Brain Tumor Therapeutics Introduction
13.2.4 Novartis Revenue in Brain Tumor Therapeutics Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Roche
13.3.1 Roche Company Details
13.3.2 Roche Business Overview
13.3.3 Roche Brain Tumor Therapeutics Introduction
13.3.4 Roche Revenue in Brain Tumor Therapeutics Business (2015-2020)
13.3.5 Roche Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Brain Tumor Therapeutics Introduction
13.4.4 Merck Revenue in Brain Tumor Therapeutics Business (2015-2020)
13.4.5 Merck Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview
13.5.3 AstraZeneca Brain Tumor Therapeutics Introduction
13.5.4 AstraZeneca Revenue in Brain Tumor Therapeutics Business (2015-2020)
13.5.5 AstraZeneca Recent Development
13.6 GE Healthcare
13.6.1 GE Healthcare Company Details
13.6.2 GE Healthcare Business Overview
13.6.3 GE Healthcare Brain Tumor Therapeutics Introduction
13.6.4 GE Healthcare Revenue in Brain Tumor Therapeutics Business (2015-2020)
13.6.5 GE Healthcare Recent Development
13.7 Hitachi Medical
13.7.1 Hitachi Medical Company Details
13.7.2 Hitachi Medical Business Overview
13.7.3 Hitachi Medical Brain Tumor Therapeutics Introduction
13.7.4 Hitachi Medical Revenue in Brain Tumor Therapeutics Business (2015-2020)
13.7.5 Hitachi Medical Recent Development
13.8 Philips Healthcare
13.8.1 Philips Healthcare Company Details
13.8.2 Philips Healthcare Business Overview
13.8.3 Philips Healthcare Brain Tumor Therapeutics Introduction
13.8.4 Philips Healthcare Revenue in Brain Tumor Therapeutics Business (2015-2020)
13.8.5 Philips Healthcare Recent Development
13.9 Novocure
13.9.1 Novocure Company Details
13.9.2 Novocure Business Overview
13.9.3 Novocure Brain Tumor Therapeutics Introduction
13.9.4 Novocure Revenue in Brain Tumor Therapeutics Business (2015-2020)
13.9.5 Novocure Recent Development
13.10 DelMar Pharmaceuticals
13.10.1 DelMar Pharmaceuticals Company Details
13.10.2 DelMar Pharmaceuticals Business Overview
13.10.3 DelMar Pharmaceuticals Brain Tumor Therapeutics Introduction
13.10.4 DelMar Pharmaceuticals Revenue in Brain Tumor Therapeutics Business (2015-2020)
13.10.5 DelMar Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Brain Tumor Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Brain Tumor Therapeutics Revenue
Table 3. Ranking of Global Top Brain Tumor Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Brain Tumor Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Radiation Therapy
Table 7. Key Players of Targeted Therapy
Table 8. Key Players of Chemotherapy
Table 9. Key Players of Immunotherapy
Table 10. Global Brain Tumor Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Brain Tumor Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Brain Tumor Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Brain Tumor Therapeutics Market Share by Regions (2015-2020)
Table 14. Global Brain Tumor Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Brain Tumor Therapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Brain Tumor Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Brain Tumor Therapeutics Players
Table 21. Global Brain Tumor Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Brain Tumor Therapeutics Market Share by Players (2015-2020)
Table 23. Global Top Brain Tumor Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Tumor Therapeutics as of 2019)
Table 24. Global Brain Tumor Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Brain Tumor Therapeutics Product Solution and Service
Table 27. Date of Enter into Brain Tumor Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Brain Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Brain Tumor Therapeutics Market Size Share by Type (2015-2020)
Table 31. Global Brain Tumor Therapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Brain Tumor Therapeutics Market Size Share by Application (2015-2020)
Table 33. Global Brain Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Brain Tumor Therapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Brain Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Brain Tumor Therapeutics Market Share (2019-2020)
Table 37. North America Brain Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Brain Tumor Therapeutics Market Share by Type (2015-2020)
Table 39. North America Brain Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Brain Tumor Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Brain Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Brain Tumor Therapeutics Market Share (2019-2020)
Table 43. Europe Brain Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Brain Tumor Therapeutics Market Share by Type (2015-2020)
Table 45. Europe Brain Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Brain Tumor Therapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Brain Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Brain Tumor Therapeutics Market Share (2019-2020)
Table 49. China Brain Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Brain Tumor Therapeutics Market Share by Type (2015-2020)
Table 51. China Brain Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Brain Tumor Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Brain Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Brain Tumor Therapeutics Market Share (2019-2020)
Table 55. Japan Brain Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Brain Tumor Therapeutics Market Share by Type (2015-2020)
Table 57. Japan Brain Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Brain Tumor Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Brain Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Brain Tumor Therapeutics Market Share (2019-2020)
Table 61. Southeast Asia Brain Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Brain Tumor Therapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Brain Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Brain Tumor Therapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Brain Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Brain Tumor Therapeutics Market Share (2019-2020)
Table 67. India Brain Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Brain Tumor Therapeutics Market Share by Type (2015-2020)
Table 69. India Brain Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Brain Tumor Therapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Brain Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Brain Tumor Therapeutics Market Share (2019-2020)
Table 73. Central & South America Brain Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Brain Tumor Therapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Brain Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Brain Tumor Therapeutics Market Share by Application (2015-2020)
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Product
Table 80. Pfizer Revenue in Brain Tumor Therapeutics Business (2015-2020) (Million US$)
Table 81. Pfizer Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Product
Table 85. Novartis Revenue in Brain Tumor Therapeutics Business (2015-2020) (Million US$)
Table 86. Novartis Recent Development
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche Product
Table 90. Roche Revenue in Brain Tumor Therapeutics Business (2015-2020) (Million US$)
Table 91. Roche Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Product
Table 95. Merck Revenue in Brain Tumor Therapeutics Business (2015-2020) (Million US$)
Table 96. Merck Recent Development
Table 97. AstraZeneca Company Details
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Product
Table 100. AstraZeneca Revenue in Brain Tumor Therapeutics Business (2015-2020) (Million US$)
Table 101. AstraZeneca Recent Development
Table 102. GE Healthcare Company Details
Table 103. GE Healthcare Business Overview
Table 104. GE Healthcare Product
Table 105. GE Healthcare Revenue in Brain Tumor Therapeutics Business (2015-2020) (Million US$)
Table 106. GE Healthcare Recent Development
Table 107. Hitachi Medical Company Details
Table 108. Hitachi Medical Business Overview
Table 109. Hitachi Medical Product
Table 110. Hitachi Medical Revenue in Brain Tumor Therapeutics Business (2015-2020) (Million US$)
Table 111. Hitachi Medical Recent Development
Table 112. Philips Healthcare Business Overview
Table 113. Philips Healthcare Product
Table 114. Philips Healthcare Company Details
Table 115. Philips Healthcare Revenue in Brain Tumor Therapeutics Business (2015-2020) (Million US$)
Table 116. Philips Healthcare Recent Development
Table 117. Novocure Company Details
Table 118. Novocure Business Overview
Table 119. Novocure Product
Table 120. Novocure Revenue in Brain Tumor Therapeutics Business (2015-2020) (Million US$)
Table 121. Novocure Recent Development
Table 122. DelMar Pharmaceuticals Company Details
Table 123. DelMar Pharmaceuticals Business Overview
Table 124. DelMar Pharmaceuticals Product
Table 125. DelMar Pharmaceuticals Revenue in Brain Tumor Therapeutics Business (2015-2020) (Million US$)
Table 126. DelMar Pharmaceuticals Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Tumor Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Radiation Therapy Features
Figure 4. Targeted Therapy Features
Figure 5. Chemotherapy Features
Figure 6. Immunotherapy Features
Figure 7. Global Brain Tumor Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Oncology Treatment Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Brain Tumor Therapeutics Report Years Considered
Figure 12. Global Brain Tumor Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Brain Tumor Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Brain Tumor Therapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Brain Tumor Therapeutics Market Share by Players in 2019
Figure 17. Global Top Brain Tumor Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Tumor Therapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Brain Tumor Therapeutics Revenue in 2019
Figure 19. North America Brain Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Brain Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Brain Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Brain Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Brain Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Brain Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Brain Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
脳腫瘍治療の世界市場（～2026年） Treatment for brain tumors depends on a number of factors including the type, location and size of the tumor as well as the patient's age and general health. Various treatments for curing brain tumor are surgery, radiation therapy, and chemotherapy, immunotherapy and so on which reduce the symptoms …- 小児脳腫瘍の世界市場（～2026年） Pediatric brain tumors are masses or growths of abnormal cells that occur in a child's brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant). Treatment and chance of recovery (prog…
- 脳腫瘍診断・治療の世界市場（～2026年） With the increasing prevalence of brain cancer, rising aging population, and growing incidences of cancer via chemical exposure, the demand of Diagnosis and treatment of brain tumors is increasing. Market Analysis and Insights: Global Brain Tumor Diagnosis and Treatments Market The global Brain Tumo…
- 固形腫瘍治療薬の世界市場（～2026年） In cancer, solid tumors are formed by aggregation of abnormal tissues that do not comprise of any liquid or cyst. Increasing incidences of solid tumor among cancer patients and growing prevalence of various types of metastatic cancers are the major factors that are expected to drive the growth of th…
- 外傷性脳損傷治療の世界市場（～2026年） Traumatic brain injury usually results from a violent blow or jolt to the head or body. Market Analysis and Insights: Global Traumatic Brain Injuries Treatment Market The global Traumatic Brain Injuries Treatment market size is projected to reach US$ 2178.1 million by 2026, from US$ 2112.1 million i…